🇺🇸 FDA
Patent

US 7285668

Process for the crystallization of (R)- or (S)-lansoprazole

granted A61KA61K31/44A61K9/5026

Quick answer

US patent 7285668 (Process for the crystallization of (R)- or (S)-lansoprazole) held by Takeda Pharmaceutical Company Limited expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/44, A61K9/5026, A61K9/5078, A61P